Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.
about
Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatmentInsulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma.Operative management for recurrent and metastatic adrenocortical carcinoma.Emerging therapy for adrenocortical carcinoma.Therapy of adrenocortical cancer: present and future.Current and emerging therapies for advanced adrenocortical carcinoma.Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care centerSurvival and prognostic factors for adrenocortical carcinoma: a single institution experience.Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States.Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.Outcomes after resection of cortisol-secreting adrenocortical carcinomaCurative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma.Adrenocortical carcinoma: past, present, and future.Management of adjuvant mitotane therapy following resection of adrenal cancer.Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.Surgical management of adrenocortical tumours.Surgical resection of synchronously metastatic adrenocortical cancer.Diagnostic and prognostic role of SF1, IGF2, Ki67, p53, adiponectin, and leptin receptors in human adrenal cortical tumors.Diagnosis, treatment and outcome of adrenocortical cancer.Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).Lymphadenectomy for Adrenocortical Carcinoma: Is There a Therapeutic Benefit?Repeated resections for liver metastasis from primary adrenocortical carcinoma: A case report.Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.Adrenocortical carcinoma: patterns of care and role of adjuvant radiation therapy-a population-based study and review of the literature.Adrenocortical carcinoma: effect of hospital volume on patient outcome.Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.Development of new preclinical models to advance adrenocortical carcinoma research.Open adrenalectomy versus laparoscopic adrenalectomy for adrenocortical carcinoma: a retrospective comparative study on short-term oncologic prognosis.European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma.Resection of adrenocortical carcinoma liver metastasis: is it justified?Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis.Adrenocortical carcinoma
P2860
Q26801839-37947B37-D877-4776-9E09-A0A60BB62ED3Q33405908-FCB43EE9-143C-4266-B7AC-EB73C91E0A78Q34061022-D0F1EE3F-76F4-4BAC-B894-83A890FEA178Q35018399-35F0D3A2-F323-491F-84F4-8479B300BF78Q35232257-C52CA0B1-3F93-4932-8789-40FE8F6BA13BQ35584305-52B1A556-A263-4999-9D5E-AA1817417D3DQ35636134-547B3EF8-2007-480B-BDCE-DF7A311074D4Q35642478-9CA60487-1BFB-49F8-8DB3-1CDC42D061F4Q35889904-CCA645BF-DAFA-48C7-A45E-8B2D25231BF8Q37114016-06D23737-6659-4155-AD96-993CF70BAB2AQ37119581-A03450D6-06C1-4C77-828D-D2D5297288E4Q37119591-DE49B085-F5C5-4ED0-A29C-D43BF9FC1DF7Q37129653-D8842EAD-9157-4881-963A-646D339AF656Q37962392-33E2C181-B664-4618-81A6-9DC7800D6997Q37999696-C73F7CCB-2206-4C4A-B27C-51A3E885362EQ38019388-535237D3-CC05-4B36-8B5D-D3E51E8163FDQ38194961-D9F92CE2-A622-4D3E-891C-205C89DF2DE2Q38196681-53C522A3-2662-426A-A874-94408EDCD96AQ38236967-A040F95B-58C3-47A2-AC59-D960B882DF6BQ38287818-02D1262B-E371-4598-B89A-2583DA525018Q38358503-16CF2ED0-4DC3-471A-ABC5-05181BC2A8D9Q38545507-E9A0078E-6B9E-406E-8AA6-DFD175D378EEQ39426991-6C01369D-D37D-453E-A180-CA0AAF44AF90Q39479211-F842EF3A-3081-4548-B121-FDBA7B31FCA6Q40509855-5AE554E1-AACD-42FE-901A-50DF31875B8EQ41559524-2206EB5B-C797-46F8-A1D9-838D14A85660Q46534855-F7FE8F23-516F-45A8-A1D8-5ADF8047D245Q47316904-CBDCFA23-75C2-478A-BECE-2AB418A7E076Q47998841-F9DA905C-974A-454A-AC82-A0403C440741Q49681867-56B4EDF8-7EC6-4A52-9328-56CCFED6B25EQ52614689-2ED4A9F7-8E2F-493B-B88E-C56BD942F88DQ52951834-0C5E07E6-5BA7-494C-BB4E-DF240DBAA7C9Q54313412-DDFD2251-ED70-4DDF-8BBA-F55FFB6C76BBQ55399185-0C1DE878-D11D-42BE-B5BB-E3D328CD9546Q57645859-E7A9C89F-4BEC-48EB-9AB3-46CEC1D0BE7D
P2860
Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Recurrence of adrenal cortical ...... qual to surgery plus mitotane.
@en
Recurrence of adrenal cortical ...... qual to surgery plus mitotane.
@nl
type
label
Recurrence of adrenal cortical ...... qual to surgery plus mitotane.
@en
Recurrence of adrenal cortical ...... qual to surgery plus mitotane.
@nl
prefLabel
Recurrence of adrenal cortical ...... qual to surgery plus mitotane.
@en
Recurrence of adrenal cortical ...... qual to surgery plus mitotane.
@nl
P2093
P1476
Recurrence of adrenal cortical ...... qual to surgery plus mitotane.
@en
P2093
Alexandria T Phan
Douglas B Evans
Elizabeth G Grubbs
Glenda G Callender
Jeffrey E Lee
Nancy D Perrier
P2888
P304
P356
10.1245/S10434-009-0716-X
P577
2009-10-23T00:00:00Z
P6179
1009990166